Dupont Capital Management Corp Illumina, Inc. Transaction History

Dupont Capital Management Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	SELL	$347.28 - $421.83 $467,091 - $567,361	-1,345 Closed	0 $0
Q3 2021 Nov 03, 2021	BUY	$405.61 - $524.84 $545,545 - $705,909	1,345 New	1,345 $546,000
Q2 2021 Jul 30, 2021	SELL	$372.84 - $481.5 $969,756 - $1.25 Million	-2,601 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$361.28 - $504.76 $939,689 - $1.31 Million	2,601 New	2,601 $999,000
Q3 2020 Oct 29, 2020	SELL	$268.51 - $400.74 $1.19 Million - $1.77 Million	-4,419 Closed	0 $0
Q2 2020 Jul 24, 2020	BUY	$256.46 - $373.01 $271,847 - $395,390	1,060 Added 31.56%	4,419 $1.64 Million
Q1 2020 Apr 29, 2020	BUY	$209.2 - $335.53 $702,702 - $1.13 Million	3,359 New	3,359 $917,000
Q2 2019 Jul 30, 2019	SELL	$300.59 - $368.15 $780,932 - $956,453	-2,598 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$272.46 - $366.54 $281,178 - $378,269	1,032 Added 65.9%	2,598 $779,000
Q3 2018 Nov 05, 2018	BUY	$279.04 - $367.06 $436,976 - $574,815	1,566 New	1,566 $575,000
Q1 2018 May 02, 2018	SELL	$209.54 - $253.91 $161,136 - $195,256	-769 Closed	0 $0
Q3 2017 Oct 31, 2017	BUY	$172.3 - $213.93 $132,498 - $164,512	769	769 $153,000

899

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.